One thing to be clear on before anything else: FeelGood operates the platform
This is tied to Medicare coverage rules and how TRICARE coordinates benefits, not a standalone expansion or rollback of TRICARE policy
Vitiligo : A randomized multicenter trial showed that afamelanotide combined with NB-UVB phototherapy achieved 48.64% mean VASI improvement versus 33.26% with phototherapy alone
Given these differences, selecting the right GLP-1RA should be based on individual patient needs, including glycemic targets, weight loss goals, tolerability, and preference for dosing frequency
But while you may not want to eat or drink anything, its important you do so that you are getting the nutrients you need
Coverage varies by state and plan